Diabetes Metab J > Volume 36(2); 2012 > Article
Koo: Letter: Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005 (Diabetes Metab J 2012;36:43-55)
The prevalence of metabolic syndrome is increasing worldwide [1,2] and is becoming a social and economic problem. Recently, the increasing prevalence of metabolic syndrome in Korea has also been reported based on the Korean National Health and Nutritional Survey (KNHANES) [3]. The age-adjusted prevalence of metabolic syndrome in adults aged ≥20 years in Korea increased significantly from 24.9% in 1998 to 31.3% in 2007, and, of five individual metabolic syndrome components, the incidence of low high density lipoprotein cholesterol (HDL-C) criteria increased the most over 10 years (13.8% of increasing) [3]. Hypertriglyceridemia also showed a significant 4.9% increase during that period [3].
Metabolic syndrome is an important risk factor for atherosclerosis [4]. It is a disease characterized by insulin resistance [5], and dyslipidemia is one of its important components [6]. However low density lipoprotein cholesterol (LDL-C) level is not included in the criteria of metabolic syndrome. Elevated LDL-C level is a major cause of coronary heart disease and other atherosclerotic disease and can provide additional information for the future risk of atherosclerosis aside from metabolic syndrome [7].
Lee et al. [8] defined dyslipidemia according to LDL-C level as well as triglyceride and HDL-C level and investigated the change of prevalence of dyslipidemia among Korean adults during 1998-2005 with KNHANES data. Considering the importance of LDL-C for the risk of atherosclerosis, this study is very important in the view of public health in Korea. Dyslipidemia in this study is defined as total cholesterol ≥240 mg/dL, LDL-C ≥160 mg/dL, HDL-C <40 mg/dL, and triglyceride ≥200 mg/dL. However, it is known that women have higher levels of HDL-C than men [9-11], and the definition of low HDL cholesterolemia in the criteria of metabolic syndrome is different in men and women according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) [6], with an HDL-C level <50 mg/dL required for women. A relatively lower prevalence of dyslipidemia in the women in this study [8] compared to that of a previous report [3] despite adding a criterion for LDL-C to the requirements of dyslipidemia might be due to a lower cutoff level of low HDL cholesterolemia in women. Based on the appropriate cutoff level of low HDL cholesterolemia for the prediction of a clinically important end-point such as coronary heart disease in the Korean population, the sex difference in HDL-C level should be considered.
Cardiovascular and cerebrovascular disease is the second most prevalent cause of death in Korea following malignancy [12], and the incidence of mortality from cardiovascular disease has persistently increased during recent years [12]. Considering that dyslipidemia is a major cause of such diseases, the study of Lee et al. [8] is important to understand the increasing tendency of dyslipidemia and the very low control rate of dyslipidemia in the Korean population and to support the need for an urgent health and medical policy plan to control dyslipidemia.


No potential conflict of interest relevant to this article was reported.


1. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 2011;34:216-219.
2. Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007;16:362-367.
3. Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34:1323-1328.
4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM;. Third National Health and Nutrition Examination Survey (NHANES III). National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-1214.
5. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
6. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
7. Kawamoto R, Tomita H, Oka Y, Kodama A, Kamitani A. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern Med 2005;44:1232-1238.
8. Lee MH, Kim HC, Ahn SV, Hur NW, Choi DP, Park CG, Suh I. Prevalence of dyslipidemia among Korean adults: Korea National Health and Nutrition Survey 1998-2005. Diabetes Metab J 2012;36:43-55.
9. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989;79:8-15.
10. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PW, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 1987;7:483-490.
11. Davis CE, Williams DH, Oganov RG, Tao SC, Rywik SL, Stein Y, Little JA. Sex difference in high density lipoprotein cholesterol in six countries. Am J Epidemiol 1996;143:1100-1106.
12. Statistics Korea: Causes of death statistics in 2010 updated 2011 Sep 8. Available from: http://kostat.go.kr/portal/korea/kor_nw/2/1/index.board?bmode=read&aSeq=250282&pageNo=11&rowNum=10&amSeq=&sTarget=&sTxt=.

Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2021 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer